Major Tobacco Manufacturer Selects LifeSphere® MultiVigilance to Automate All Global Internal Adverse Event Management Processes
A multinational tobacco products manufacturing company recently selected ArisGlobal’s LifeSphere® MultiVigilance 10, industry’s first and only automated adverse event platform for their global safety vigilance needs.
Linical a market-leading, midsized, global contract research organization (CRO) adopted ArisGlobal’s LifeSphere MultiVigilance as their primary global safety management system, industry’s first and only automated adverse event platform.
ArisGlobal announced it has made a number of new key leadership hires, with the express purpose of preparing for accelerated growth in North America, Europe, and Asia, and new product launches in 2020, according to President and CEO Sankesh Abbhi.
ArisGlobal and Soterius Extend Partnership with Global Delivery of LifeSphere® MultiVigilance and LifeSphere® Medical Information
ArisGlobal has expanded its partnership with Soterius, Inc., a global leader in providing drug safety and medical outsourcing services and solutions adding LifeSphere® MultiVigilance and LifeSphere® Medical Information to their service-oriented technology stack.
ArisGlobal’s LifeSphere MultiVigilance Goes Live with Top 5 Pharma, Delivering a Next-Generation Safety System to 2,300+ End Users
ArisGlobal successfully delivered the industry’s largest drug safety system implementation, going live on-time with its next-generation LifeSphere® MultiVigilance offering. LifeSphere MultiVigilance 10 is the industry’s only end-to-end safety system offering production-ready automation.
10 Life Sciences Companies Switch to ArisGlobal’s LifeSphere® MultiVigilance from Competing Safety Systems
ArisGlobal is proud to announce that ten life sciences companies have switched to its industry-leading LifeSphere® MultiVigilance drug safety system within the past 12 months. LifeSphere MultiVigilance is a next-generation, end-to-end safety system that has been developed in close partnership with industry leaders, including the FDA, Boehringer Ingelheim, Teva and AbbVie, among others.
ArisGlobal Releases Comprehensive Automated Literature Monitoring Solution for Improved Pharmacovigilance
ArisGlobal, the visionary technology provider of automated solutions for the life sciences industry, today announced the availability of LifeSphere® LitPro (LSLP), the life science industry’s first and only solution that effectively automates all steps in the medical literature monitoring (MLM) process required by most regulatory agencies.
ArisGlobal Announces LifeSphere® MultiVigilance 10, Industry’s First End-to-End Safety System with Production-Ready Automation
ArisGlobal, the visionary provider of drug development technology for the life sciences industry, today announced the availability of LifeSphere® MultiVigilance 10 (LSMV10), the industry’s only end-to-end drug safety system with production-ready automation.
Santen Pharmaceutical establishes a safety database with ArisGlobal’s LifeSphere® MultiVigilance multi-tenant drug safety suite to improve and streamline pharmacovigilance at a global scale
Santen Pharmaceutical Co., Ltd., the leader in ophtalmicdrug development, has selected ArisGlobal to create a single global safety database and improve the efficiency and quality of their global safety vigilance processes. Santen Pharmaceutical’s safety suite will include ArisGlobal’s LifeSphere® MultiVigilance (LSMV), LifeSphere® Reporting and Analytics and LifeSphere® Intake and Triage solutions to automate key safety vigilance activities, reduce costs, and increase compliance.
ArisGlobal Will Showcase New Automation Solutions and Strategies to Industry Leaders at 2019 Life Sciences Technology Summit
ArisGlobal today announced details of its annual Life Sciences Technology Summit (AGLSTS 2019), taking place October 1st – 3rd at the Miami Beach EDITION hotel in Miami Beach, Florida. The 3-day event will bring together senior executives, IT and business practitioners, and industry experts across drug safety, regulatory affairs, clinical development, and medical affairs to discuss how a unified platform and automation technology can transform the drug development process.
ArisGlobal Safety Expert to Present “How to Fully Leverage Automation in PV – A Real Case Study” at World Drug Safety Congress Europe
ArisGlobal, LLC, a leading provider of life sciences software that automates core drug development functions for over 250 life sciences companies, will present a session titled “How to Fully Leverage Automation in PV – A Real Case Study” at the upcoming World Drug Safety Congress Europe 2019, September 10-11, 2019 at the Hotel Hilton Amsterdam, Amsterdam, Netherlands.
Nordic Capital, a leading private equity investor with deep experience in healthcare and technology has entered into a definitive agreement to acquire ArisGlobal.